CVS Health appoints David Joyner as President and CEO, effective October 17, replacing Karen Lynch.
CVS Health has named David Joyner as its new President and CEO, effective October 17, replacing Karen Lynch. Joyner, with over 37 years in healthcare, previously served as CVS Caremark's president. His appointment comes amid challenges, including a nearly 20% drop in share prices and rising medical costs impacting Aetna. CVS anticipates adjusted earnings of $1.05 to $1.10 per share for Q3 2024, along with cost-cutting measures and restructuring charges.
October 18, 2024
161 Articles